Cargando…

HLA alleles associated with asparaginase hypersensitivity in Chinese children

Asparaginase is an important drug to treat childhood haematological malignancies. Data on the association between human leukocyte antigens (HLA) and asparaginase hypersensitivity among Chinese are lacking. We conducted a retrospective study to identify HLA alleles associated with asparaginase hypers...

Descripción completa

Detalles Bibliográficos
Autores principales: Chua, Gilbert T., Rosa Duque, Jaime S., Cheuk, Daniel Ka Leung, Leung, Alex Wing Kwan, Wong, Wilfred Hing Sang, Liu, Anthony Pak Yin, Lee, Pamela P. W., Ha, Shau Yin, Chiang, Alan Kwok Shing, Ho, Marco Hok Kung, Chu, Wai Keung, Chan, Yuk Sing, Luk, Chun Wing, Ling, Alvin Siu Cheung, Kwan, Mike Yat Wah, Yiu, Oscar Kuen Fong, Wong, Ian Chi Kei, Lau, Yu Lung, Li, Chi Kong, Leung, Wing Hang, Chan, Godfrey Chi Fung, Ip, Patrick, Kwok, Janette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557538/
https://www.ncbi.nlm.nih.gov/pubmed/34717720
http://dx.doi.org/10.1186/s13045-021-01201-3
Descripción
Sumario:Asparaginase is an important drug to treat childhood haematological malignancies. Data on the association between human leukocyte antigens (HLA) and asparaginase hypersensitivity among Chinese are lacking. We conducted a retrospective study to identify HLA alleles associated with asparaginase hypersensitivity among Chinese children with acute lymphoblastic leukaemia (ALL), mixed phenotype leukaemia and non-Hodgkin lymphoma (NHL), who received asparaginases with HLA typing performed between 2009 and 2019. 107 Chinese patients were analysed. 66.3% (71/107) developed hypersensitivity to at least one of the asparaginases. HLA-B*46:01 (OR 3.8, 95% CI 1.4–10.1, p < 0.01) and DRB1*09:01 (OR 4.3, 95% CI 1.6–11.4, p < 0.01) were significantly associated with l-asparaginase hypersensitivities, which remained significant after adjustment for age, gender and B cell ALL [HLA-B*46:01 (adjusted OR 3.5, 95% 1.3–10.5, p = 0.02) and DRB1*09:01 (OR 4.4, 95% CI 1.6–13.3, p < 0.01)]. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13045-021-01201-3.